These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 9814563

  • 1. Pulmonary Tc-99m tetrofosmin imaging: clinical experience with detecting malignant lesions and monitoring response to therapy.
    Basoglu T, Bernay I, Coskun C, Canbaz F, Talu A, Erkan L.
    Clin Nucl Med; 1998 Nov; 23(11):753-7. PubMed ID: 9814563
    [Abstract] [Full Text] [Related]

  • 2. 99mTc-tetrofosmin scintigraphy in musculoskeletal tumours: the relationship between P-glycoprotein expression and tetrofosmin uptake in malignant lesions.
    Yapar Z, Kibar M, Ozbarlas S, Yapar AF, Uguz A, Zorludemir S, Herdem M.
    Nucl Med Commun; 2002 Oct; 23(10):991-1000. PubMed ID: 12352598
    [Abstract] [Full Text] [Related]

  • 3. The value of Tc-99m-tetrofosmin scintigraphy in the assessment of P-glycoprotein in patients with malignant bone and soft-tissue tumors.
    Yapar Z, Kibar M, Yapar AF, Uguz A, Ozbarlas S, Gonlusen G.
    Ann Nucl Med; 2003 Sep; 17(6):443-9. PubMed ID: 14575377
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Technetium-99m-tetrofosmin scintigraphy in pulmonary tuberculosis.
    Degirmenci B, Kilinc O, Cirak KA, Capa G, Akpinar O, Halilcolar H, Durak H, Akkoclu A, Derebek E, Ucan ES.
    J Nucl Med; 1998 Dec; 39(12):2116-20. PubMed ID: 9867153
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Technetium-99m-tetrofosmin uptake in malignant lung tumours.
    Başoğlu T, Sahin M, Coşkun C, Koparan A, Bernay I, Erkan L.
    Eur J Nucl Med; 1995 Jul; 22(7):687-9. PubMed ID: 7498232
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Evaluation of malignant and benign lung lesions with 99Tcm-tetrofosmin.
    Atasever T, Gökcora N, Vural G, Cetin N, Oztürk C, Unlü M.
    Nucl Med Commun; 1996 Jul; 17(7):577-82. PubMed ID: 8843116
    [Abstract] [Full Text] [Related]

  • 13. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
    Lind P, Gallowitsch HJ.
    Acta Med Austriaca; 1996 Jul; 23(1-2):69-75. PubMed ID: 8767519
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Low uptake of Tc-99m tetrofosmin in lung cancer: a case report.
    Franc B, Goris M.
    Clin Nucl Med; 2002 Oct; 27(10):698-700. PubMed ID: 12352109
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Technetium-99m-tetrofosmin scintigraphy in the prediction of chemotherapy response of untreated malignant lymphomas and comparison with other prognostic factors.
    Sun SS, Tsai SC, Wang JJ, Ho YJ, Ho ST, Kao CH.
    Anticancer Res; 2001 Oct; 21(1B):685-8. PubMed ID: 11299826
    [Abstract] [Full Text] [Related]

  • 19. Technetium-99m tetrofosmin single photon emission computed tomography in the evaluation of suspected lung cancer.
    Schillaci O, Monteleone F, D'Andrea N, Picardi V, Cangemi R, Cangemi V, Scopinaro F.
    Cancer Biother Radiopharm; 1999 Apr; 14(2):129-34. PubMed ID: 10850296
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.